Relmada doses 25% of subjects in Phase ll trial of dextromethadone
Relmada Therapeutics has completed dosing on 25% of the planned subjects in its Phase ll...
Relmada Therapeutics has completed dosing on 25% of the planned subjects in its Phase ll...